Biphenyl

Biphenyl

SCHEMBL986473

c1c[nH]cn1.c1ccc(-c2ccccc2)cc1

nearest known ligand 0.62

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.62
FKBP5 Q13451 1/20 0.62
NOTUM Q6P988 2/20 0.50
ATM Q13315 1/20 0.41
NISCH Q9Y2I1 3/20 0.40
CYP3A4 P08684 2/20 0.40
IDO1 P14902 1/20 0.40
MTOR P42345 1/20 0.40
ADK P55263 1/20 0.40
SCN4A P35499 1/20 0.37
AKT1 P31749 1/20 0.37
AKT2 P31751 1/20 0.37
ALOX15 P16050 2/20 0.36
CYP19A1 P11511 1/20 0.35
MEN1 O00255 1/20 0.35
TSHR P16473 1/20 0.35
KMT2A Q03164 1/20 0.35
NPC1 O15118 3/20 0.35
RAB9A P51151 3/20 0.35
MAPK1 P28482 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Biphenyl SCHEMBL27756385 1.00 ALDH1A1 (0.62) ALDH1A1FKBP5NOTUMATMNISCH
Biphenyl SCHEMBL28667880 0.98 ALDH1A1 (0.59) ALDH1A1FKBP5NOTUMATMNISCH
Biphenyl SCHEMBL28151555 0.98 ALDH1A1 (0.59) ALDH1A1FKBP5NOTUMATMNISCH
Biphenyl SCHEMBL1838047 0.88 ALDH1A1 (0.48) ALDH1A1FKBP5NOTUMATMNISCH
Imidazole SCHEMBL28051713 0.88 CYP2A6 (0.56) ALDH1A1FKBP5CYP3A4ALOX15CYP19A1
Imidazole SCHEMBL28940828 0.88 ALDH1A1 (0.48) ALDH1A1FKBP5NOTUMCYP19A1SMN1; SMN2
Imidazole SCHEMBL3629127 0.85 ALDH1A1 (0.54) ALDH1A1FKBP5NOTUMNISCHCYP3A4
Benzene SCHEMBL18279961 0.84 ALDH1A1 (0.87) ALDH1A1FKBP5TSHR
Benzene SCHEMBL5088215 0.84 ALDH1A1 (0.87) ALDH1A1FKBP5TSHR
Benzene SCHEMBL29168770 0.84 ALDH1A1 (0.87) ALDH1A1FKBP5TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 326 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119899491-A Glue solution for halogen-free antimony-free flame-retardant laminated board, prepreg, laminated board, manufacturing method and resin composition 上海国纪电子材料有限公司 2025-04-29 CN claimed
CN-119875304-A Glue solution for halogen-free antimony-free flame-retardant laminated board, prepreg, laminated board, preparation method and resin composition 上海国纪电子材料有限公司 2025-04-25 CN claimed
CN-119638957-A Epoxy resin prepreg, adhesive film, copper foil substrate and preparation method of prepreg 江西省航宇新材料股份有限公司 2025-03-18 CN claimed
CN-119552515-A Coordination vulcanized organic silicon rubber foaming material and preparation and recycling methods thereof 常州市顺祥新材料科技股份有限公司 2025-03-04 CN claimed
CN-119176781-A Conjugated diene ionic liquid and preparation method and application thereof 中国石油化工股份有限公司 2024-12-24 CN claimed
CN-118978885-A High-temperature-resistant epoxy resin inductance flexible glue and preparation method thereof 惠州盛世达科技有限公司 2024-11-19 CN claimed
CN-118205273-B Functional fabric with radiation-proof antibacterial effect and production method thereof 海安润腾纺织科技有限公司 2024-10-18 CN claimed
CN-118782717-A Preparation method and application of zinc ion battery cathode 五邑大学 2024-10-15 CN claimed
CN-118667537-A Construction and formula of organic single-molecule-based white light gel system 怀化学院 2024-09-20 CN claimed
CN-118598414-A Ternary wastewater recycling treatment method 江西佳纳能源科技有限公司 2024-09-06 CN claimed
US-20110263543-A1 ANTI INFLAMMATORY COMPOUNDS ELDER PHARMACEUTICALS LTD. (IN) 2011-10-27 US claimed
EP-2321281-A2 ANTI INFLAMMATORY COMPOUNDS Elder Pharmaceuticals Ltd (IN) 2011-05-18 EP claimed
US-7868180-B2 Process for the preparation of sartan derivatives and intermediates useful in such process KRKA, D.D. NOVO MESTO (SI) 2011-01-11 US claimed
WO-2010029576-A2 ANTI INFLAMMATORY COMPOUNDS ELDER PHARMACEUTICALS LTD. (IN) 2010-03-18 WO claimed
CN-101538193-A Method for preparing compounds containing difluoromethyl SHANGHAI INST ORGANIC CHEM 2009-09-23 CN claimed
CN-101328143-A Fluorine-containing sulphoxide imines compounds, synthetic methods and uses sthereof SHANGHAI INST ORGANIC CHEM (CN) 2008-12-24 CN claimed
US-20080312451-A1 Process For the Preparation of Sartan Derivatives and Intermediates Useful in Such Process KRKA, D.D. NOVO MESTO (SK) 2008-12-18 US claimed
EP-1931655-A2 A PROCESS FOR THE PREPARATION OF SARTAN DERIVATIVES AND INTERMEDIATES USEFUL IN SUCH PROCESS KRKA, D.D., Novo Mesto (SI) 2008-06-18 EP claimed
WO-2007039117-A2 A PROCESS FOR THE PREPARATION OF SARTAN DERIVATIVES AND INTERMEDIATES USEFUL IN SUCH PROCESS KRKA, D.D., NOVO, MESTO (SI) 2007-04-12 WO claimed
EP-1764365-A1 A process for the preparation of sartan derivates and intermediates useful in such process KRKA, D.D., Novo Mesto (SI) 2007-03-21 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110263543-A1 ANTI INFLAMMATORY COMPOUNDS IL1B, LITAF, IL6 ALDH1A1 197/4885FKBP5 2600/4885NOTUM 845/4885
US-20080312451-A1 Process For the Preparation of Sartan Derivatives and Intermediates Useful in Such Process MC5R, NPY5R, ADRA1D ALDH1A1 3228/4885FKBP5 1612/4885NOTUM 3883/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.